Skip to content

Intervention for Smoking Cessation in Pre-Surgical Patients.

Evaluación de la Eficacia de Una intervención Para Dejar de Fumar en Pacientes prequirúrgicos de cirugía ortopédica o de cirugía General y urológica: Ensayo clínico Aleatorizado.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05961813
Enrollment
232
Registered
2023-07-27
Start date
2023-05-20
Completion date
2026-01-01
Last updated
2023-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking, Smoking Cessation, Surgical Procedure, Unspecified

Keywords

Smoking, Smoking Cessation, Tobacco Use Disorder, Surgery

Brief summary

The goal of this clinical trial is to assess efficacy of an intensive pre-surgical intervention to quit smoking in smoking patients who will be operated on implant orthopedic surgery or general and urological surgery. The main question\[s\] it aims to answer are: * Evaluate the efficacy of intensive pre surgical intervention to quit smoking compared to a brief intervention * Evaluate the implementation of this protocol. Participants will be randomized to 2 intervention groups (patients programmed for protesic implant orthopedic surgery in the first group, and general and urological surgery) and 2 control groups (stratified in the same manner as the intervention groups), and will be monitored through telematic check ups via phone calls.

Detailed description

1. Subject recruitment in pre surgical anesthesiology consults, data collection and randomization within 48 hours of said visit. 2. Subjects in the intensive intervention group will be sent to a specialized Preventive Medicine consult for smoking cessation, completing 6 visits (2 before surgical intervention, 4 visits withint the following 12 months). Subjects in the control group will receive brief advice on quitting smoking through a phone call the the same day randomization is performed. Both groups will receive follow up calls at months 1, 3, 6, and 12, after surgical intervetion. All patients will have their smoking habits evaluated and the relevant data about the surgical intervention collected the day of the intervention. 3. At month 7 adecuacy of the protocol will be evaluated to assess if any modifications are necessary. 4. Data entry and quality control of the database will be performed periodically for the duration of the study.

Interventions

BEHAVIORALIntensive intervention for smoking cessation

Patients will be given a brochure and presentation on smoking cessation and will complete 6 visits (2 before surgical intervention, 4 visits within the following 12 months), as well as follow up phone calls for progressi monitorization.

BEHAVIORALBrief intervention for smoking cessation

Patients will be given a brochure and presentation on smoking cessation 4 weeks before surgery, as well as follow up phone calls for progressi monitorization.

Sponsors

Hospital Universitari Vall d'Hebron Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized, open, controlled clinical trial.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients must 18 years old or older, and be able to consent. * Surgery programmed for at least 4 weeks after inclusion in the study. * Smokers

Exclusion criteria

* Pregnancy * Already under treatment for smoking cessation * Inability to consent due to cognitive impairment or language barrier. * Non-primary knee or hip replacement surgery * Participation in any study that forbids use of nicotine substitution therapy (dermal, oral)

Design outcomes

Primary

MeasureTime frameDescription
Tobacco useEvaluated at 1, 3, 6, and 12 months after surgical interventionChange in self reported tobacco use (smoking)

Secondary

MeasureTime frameDescription
Changes in rate of different type of tobbaco product usersEvaluated at recruitment, and 1, 3, 6, and 12 months after surgical interventionCigarettes, cigars, rolling tobacco, etc.
Changes in tobacco use patternEvaluated at recruitment, and 1, 3, 6, and 12 months after surgical interventionAmount and frequency (daily, weekly, sporadically)
Changes in degree of nicotine dependencyEvaluated at recruitment, and 1, 3, 6, and 12 months after surgical interventionFagerström test \[low dependency (0-3), medium dependency (4-6), y high dependency (7-10)\]
Changes in disposition to smoking cessationEvaluated at recruitment, and 1, 3, 6, and 12 months after surgical interventionProchaska and Di Clemente's model (pre contemplation, contemplation, preparation, action, maintenance or relapse)
Changes in Motivation levelEvaluated at recruitment, and 1, 3, 6, and 12 months after surgical interventionRichmond's test (\<3 no motivation; 4-5 doubtful motivation; 6-7 moderate motivation; 8-10 high motivation)
Changes in concentration of exhaled CO measured with a CO-oximeterEvaluated at recruitment, and 1, 3, 6, and 12 months after surgical interventionA patient will be considered as an active tobacco user if more than 6 of carboxyhemoglobin particles per million are found through the use of a CO-oximeter
Number of patients with surgical complicatoinsHospitalization period and 90 days after surgical intervention.Complications will be classified as respiratory, cardiovascular, surgical wound and complications, mortality
Surgery durationDay of interventionTime spent in the operation room
Need of blood transfusionDay of interventionVolume of blood transfused during surgery
Hospitalization durationDays from admitting until discharge.Number of days of hospitalization after surgery.
Need of new hospitalizations12 months after surgical intervention.Number of times patient is admitted to the hospital during follow up
Changes in self-efficacyEvaluated at recruitment, and 1, 3, 6, and 12 months after surgical interventionAlbert Bandura's social cognitive theory

Countries

Spain

Contacts

Primary ContactEva Gavilán Castillo, RN; MSN
eva.gavilan@vallhebron.cat934893000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026